Osteoporosis is defined as a systemic skeletal disorder characterized by low bone
mass and microarchitectural deterioration of bone tissue, with a consequent increase
in bone fragility and susceptibility to fractures. Osteoporosis historically has been
considered an adult condition because of its increasing incidence with age, affecting
one in five postmenopausal women [
[1]
]. Osteoporosis is also costly, as the US Surgeon General reported that the estimated
annual cost to the United States health system for all osteoporosis-related fractures
ranged from $12.2 to $17.9 billion in 2002 [
[2]
].United States Department of Health & HumanServices. Bone health and osteoporosis: a report of the Surgeon General, 2006 [article online]. Available at: http://www.surgeongeneral.gov/library/bonehealth. Accessed 11 April, 2006.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Advances in PediatricsAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
National Osteoporosis Foundation. Impact and overview 2006.
United States Department of Health & HumanServices. Bone health and osteoporosis: a report of the Surgeon General, 2006 [article online]. Available at: http://www.surgeongeneral.gov/library/bonehealth. Accessed 11 April, 2006.
- Normal acquisition and loss of bone mass.Horm Res. 2003; 60: 71-76
- Quantitative bone analysis in children: current methods and recommendations.J Pediatr. 2005; 146: 726-731
- Males have larger skeletal size and bone mass than females, despite comparable body size.J Bone Miner Res. 2005; 20: 529-535
- Bone mineral acquisition in healthy Asian, Hispanic, Black, and Caucasian youth: a longitudinal study.J Clin Endocrinol Metab. 1999; 84: 4702-4712
- Reduced bone mass in daughters of women with osteoporosis.N Engl J Med. 1989; 320: 554-558
- Genetics of osteoporosis.Mol Genet Metab. 2006; 88: 295-306
Online Mendelian Inheritance in Man, OMIM 259770, 2001 [article online]. Available at: www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=259770. Accessed 7 December, 2006.
Online Mendelian Inheritance in Man, OMIM 601884, 2006 [article online]. Available at: www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=601884. Accessed 7 December, 2006.
- Effects of cyclical etidronate combined with calcitriol versus cyclical etidronate alone on spine and femoral neck bone mineral density in postmenopausal osteoporotic women.Ann Rheum Dis. 1998; 57: 346-349
- Calcium potentiates the effect of estrogen and calcitonin on bone mass: review and analysis.Am J Clin Nutr. 1998; 67: 18-24
- Calcium and vitamin D3 supplementation prevents bone loss in the spine secondary to low-dose corticosteroids in patients with rheumatoid arthritis. A randomized, double-blind, placebo-controlled trial.Ann Intern Med. 1996; 125: 961-968
- Regional specificity of exercise and calcium during skeletal growth in girls: a randomized controlled trial.J Bone Miner Res. 2003; 18: 156-162
- A positive dose–response effect of vitamin D supplementation on site-specific bone mineral augmentation in adolescent girls: a double-blinded randomized placebo-controlled 1-year intervention.J Bone Miner Res. 2006; 21: 836-844
- Effects of calcium supplementation on bone density in healthy children: meta-analysis of randomised controlled trials.BMJ. 2006; 333: 775
- Teenaged girls, carbonated beverage consumption, and bone fractures.Arch Pediatr Adolesc Med. 2000; 154: 610-613
- Dietary reference intakes for calcium, phosphorus, magnesium, vitamin D, and fluoride.National Academy Press, Washington, DC1997
- American Academy of Pediatrics. Committee on Nutrition. Calcium requirements of infants, children, and adolescents.Pediatrics. 1999; 104: 1152-1157
- Vitamin D deficiency in pregnant and breast-feeding women and their infants.J Perinatol. 1997; 17: 10-14
- Nutritional rickets with normal circulating 25-hydroxyvitamin D: a call for re-examining the role of dietary calcium intake in North American infants.J Clin Endocrinol Metab. 2003; 88: 3539-3545
- Nutritional rickets in suburbia.J Am Coll Nutr. 1998; 17: 637-641
- Hypovitaminosis D in healthy schoolchildren.Pediatrics. 2001; 107: E53
- Vitamin D: a necessity for children and adolescents in Greece.Calcif Tissue Int. 2005; 77: 348-355
- Institute of Medicine, Standing Committee on the Scientific Evaluation of Dietary Reference Intakes. Dietary reference intakes for calcium phosphorus, magnesium, vitamin D and fluoride.National Academy Press, Washington, DC1997
- The relation of dietary vitamin C intake to bone mineral density: results from the PEPI study.Calcif Tissue Int. 1998; 63: 183-189
- Vitamin K2 (menatetrenone) effectively prevents fractures and sustains lumbar bone mineral density in osteoporosis.J Bone Miner Res. 2000; 15: 515-521
- Jumping improves hip and lumbar spine bone mass in prepubescent children: a randomized controlled trial.J Bone Miner Res. 2001; 16: 148-156
- A school-based exercise intervention elicits substantial bone health benefits: a 2-year randomized controlled trial in girls.Pediatrics. 2003; 112: e447
- Effect of a calcium and exercise intervention on the bone mineral status of 16-18-y-old adolescent girls.Am J Clin Nutr. 2003; 77: 985-992
- Self-reported lifetime physical activity and areal bone mineral density in healthy postmenopausal women: the importance of teenage activity.Calcif Tissue Int. 2006; 79: 214-222
- Alcohol intake as a risk factor for fracture.Osteoporos Int. 2005; 16: 737-742
- Smoking and fracture risk: a meta-analysis.Osteoporos Int. 2005; 16: 155-162
- A meta-analysis of the effects of cigarette smoking on bone mineral density.Calcif Tissue Int. 2001; 68: 259-270
- Smoking in young men is associated with lower bone mineral density and reduced cortical thickness.J Clin Endocrinol Metab. 2007; 92: 497-503
- Bisphosphonate treatment in osteogenesis imperfecta: which drug, for whom, for how long?.Ann Med. 2005; 37: 295-302
- Osteogenesis imperfecta, current and future medical treatment.Am J Med Genet C Semin Med Genet. 2005; 139: 31-37
- Testing for osteogenesis imperfecta in cases of suspected nonaccidental injury.J Med Genet. 2002; 39: 382-386
- Osteogenesis imperfecta type VI: a form of brittle bone disease with a mineralization defect.J Bone Miner Res. 2002; 17: 30-38
- Type V osteogenesis imperfecta: a new form of brittle bone disease.J Bone Miner Res. 2000; 15: 1650-1658
- Osteogenesis imperfecta type VII: an autosomal recessive form of brittle bone disease.Bone. 2002; 31: 12-18
- Genetic heterogeneity in osteogenesis imperfecta.J Med Genet. 1979; 16: 101-116
- Relationships between vitamin D, parathyroid hormone, and bone mineral density in inflammatory bowel disease.J Intern Med. 1996; 239: 131-137
- Osteoporosis in adult patients with celiac disease.Bone. 1999; 24: 249-255
- Local and systemic factors in the pathogenesis of osteoporosis.N Engl J Med. 1988; 318: 818-828
- The tumor necrosis factor system and leptin in coeliac disease.An Esp Pediatr. 2001; 55: 198-204
- Reduced bone mineral content in adult patients with growth hormone deficiency.Acta Endocrinol (Copenh). 1993; 129: 201-206
- Reduced bone mineral density in patients with adult-onset growth hormone deficiency.J Clin Endocrinol Metab. 1994; 78: 669-674
- Low vertebral cancellous bone density in peri-pubertal girls with Turner's syndrome and boys with hypogonadism.J Pediatr Endocrinol Metab. 2002; 15: 1537-1542
- The skeletal phenotype of men with previous constitutional delay of puberty.J Clin Endocrinol Metab. 2004; 89: 4306-4311
- Thyroid hormones increase insulin-like growth factor I content in the medium of rat bone tissue.J Bone Miner Res. 1993; 8: 1475-1481
- Serum interleukin-6 and bone metabolism in patients with thyroid function disorders.J Clin Endocrinol Metab. 1997; 82: 78-81
- Glucocorticoid effects on bone.J Clin Endocrinol Metab. 1998; 83: 1860-1862
- The effect of Cushing's disease on bone mineral density, body composition, growth, and puberty: a report of an identical adolescent twin pair.J Clin Endocrinol Metab. 1996; 81: 1905-1911
- Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone.J Clin Invest. 1998; 102: 274-282
- Glucocorticoid decreases circulating osteoprotegerin (OPG): possible mechanism for glucocorticoid-induced osteoporosis.Nephrol Dial Transplant. 2001; 16: 479-482
- Insulin-like growth factor I mediates selective anabolic effects of parathyroid hormone in bone cultures.J Clin Invest. 1989; 83: 60-65
- Parathyroid hormone stimulates release of insulin-like growth factor-I (IGF-I) and IGF-II from neonatal mouse calvaria in organ culture.Endocrinology. 1989; 125: 1484-1491
- Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone.J Clin Invest. 1999; 104: 439-446
- Mediators of the biphasic responses of bone to intermittent and continuously administered parathyroid hormone.J Cell Biochem. 2003; 89: 180-190
- Catabolic effects of continuous human PTH (1–38) in vivo is associated with sustained stimulation of RANKL and inhibition of osteoprotegerin and gene-associated bone formation.Endocrinology. 2001; 142: 4047-4054
- Continuous PTH and PTHrP infusion causes suppression of bone formation and discordant effects on 1,25(OH)2 vitamin D.J Bone Miner Res. 2005; 20: 1792-1803
- Primary hyperparathyroidism in a paediatric hospital.QJM. 1996; 89: 921-932
- Primary hyperparathyroidism in children and adolescents: the Johns Hopkins Children's Center experience 1984-2001.J Bone Miner Res. 2002; 17: N44-N50
- Primary hyperparathyroidism in pediatric patients.Pediatrics. 2005; 115: 974-980
- Osteopenia in children who have undergone posterior fossa or craniospinal irradiation for brain tumors.Arch Pediatr Adolesc Med. 2004; 158: 491-496
- Cross-sectional study of bone mineral density in adult survivors of solid pediatric cancers.J Pediatr Hematol Oncol. 2005; 27: 248-253
- Bone mineral density in survivors of childhood acute lymphoblastic leukemia.Turk J Pediatr. 2006; 48: 101-104
- Altered bone mineral density and body composition, and increased fracture risk in childhood acute lymphoblastic leukemia.J Pediatr. 2002; 141: 204-210
- Bone mineral assessment with tibial ultrasonometry and dual-energy X-ray absorptiometry in long-term survivors of acute lymphoblastic leukemia in childhood.J Clin Densitom. 2002; 5: 167-173
- Normal bone mineral density after treatment for childhood acute lymphoblastic leukemia diagnosed between 1991 and 1998.J Pediatr. 2001; 138: 898-904
- Bone mineral density and bone metabolism in children treated for bone sarcomas.Pediatr Res. 2006; 59: 866-871
- Decreased bone density in adolescent girls with anorexia nervosa.Pediatrics. 1990; 86: 440-447
- Severity of osteopenia in estrogen-deficient women with anorexia nervosa and hypothalamic amenorrhea.J Clin Endocrinol Metab. 1999; 84: 2049-2055
- Alterations in cortisol secretory dynamics in adolescent girls with anorexia nervosa and effects on bone metabolism.J Clin Endocrinol Metab. 2004; 89: 4972-4980
- Osteoporosis in women with anorexia nervosa.N Engl J Med. 1984; 311: 1601-1606
- Outcome of bone mineral density in anorexia nervosa patients 11.7 years after first admission.J Bone Miner Res. 1993; 8: 597-605
- Prevalence of reduced bone mass in children and adults with spastic quadriplegia.Dev Med Child Neurol. 2003; 45: 12-16
World Health Organization (WHO): assessment of fracture risk and its application to screening for postmenopausal osteoporosis: report of the WHO study group. Geneva (IL); 1994. WHO Technical Report Series 843. WHO.
- The Writing Group for the ISCD Position Conference. Diagnosis of osteoporosis in men, premenopausal women, and children.J Clin Densitom. 2004; 7: 17-26
- Noninvasive techniques for bone mass measurement.in: Glorieux F.H. Pettifor J.M. Juppner H. Pediatric bone: biology and diseases. Academic Press, San Diego (CA)2003: 303-324
- Measuring bone mass in children: can we really do it?.Horm Res. 2006; 65: 11-16
- Interpretation of whole body dual energy X-ray absorptiometry measures in children: comparison with peripheral quantitative computed tomography.Bone. 2004; 34: 1044-1052
- Can geometry-based parameters from pQCT and material parameters from quantitative ultrasound (QUS) improve the prediction of radial bone strength over that by bone mass (DXA)?.Osteoporos Int. 2004; 15: 375-381
- The role of ultrasound in the assessment of osteoporosis: a review.Osteoporos Int. 1997; 7: 7-22
- Bone mineral density in girls with forearm fractures.J Bone Miner Res. 1998; 13: 143-148
- More broken bones: a 4-year double cohort study of young girls with and without distal forearm fractures.J Bone Miner Res. 2000; 15: 2011-2018
- Increased body weight and decreased radial cross-sectional dimensions in girls with forearm fractures.J Bone Miner Res. 2001; 16: 1337-1342
- Bone mineral density in children and adolescents who have spastic cerebral palsy.J Bone Joint Surg Am. 1995; 77: 1671-1681
- Bone mineral density and bone metabolism in Duchenne muscular dystrophy.Osteoporos Int. 2003; 14: 761-767
- Guide to bone health and disease in cystic fibrosis.J Clin Endocrinol Metab. 2005; 90: 1888-1896
- Guidelines on the use of biochemical markers of bone turnover in osteoporosis (2001).J Bone Miner Metab. 2001; 19: 338-344
- Relationship of bone turnover to bone density and fractures.J Bone Miner Res. 1997; 12: 1083-1091
- Biochemical markers of bone turnover. Applications for osteoporosis.Endocrinol Metab Clin North Am. 1998; 27: 303-323
- The predictive role of bone turnover markers for BMD in middle-aged men.Aging Male. 2006; 9: 97-102
- Bone health in children and adolescents: a symposium at the annual meeting of the Pediatric Academic Societies/Lawson Wilkins Pediatric Endocrine Society, May 2003.Curr Probl Pediatr Adolesc Health Care. 2004; 34: 226-242
- Cyclic administration of pamidronate in children with severe osteogenesis imperfecta.N Engl J Med. 1998; 339: 947-952
- Pamidronate treatment of severe osteogenesis imperfecta in children under 3 years of age.J Clin Endocrinol Metab. 2000; 85: 1846-1850
- Efficacy and safety of alendronate for the treatment of osteoporosis in diffuse connective tissue diseases in children: a prospective multicenter study.Arthritis Rheum. 2000; 43: 1960-1966
- Bisphosphonates to treat osteopenia in children with quadriplegic cerebral palsy: a randomized, placebo-controlled clinical trial.J Pediatr. 2002; 141: 644-651
- Pamidronate treatment in bone fibrous dysplasia in children and adolescents with McCune-Albright syndrome.J Pediatr Endocrinol Metab. 2002; 15: 929-937
- Beneficial effect of long-term intravenous bisphosphonate treatment of osteogenesis imperfecta.Arch Dis Child. 2002; 86: 356-364
- Pamidronate treatment of osteogenesis imperfecta—lack of correlation between clinical severity, age at onset of treatment, predicted collagen mutation, and treatment response.J Pediatr Endocrinol Metab. 2002; 15: 163-174
- Bone mass, size, and density in children and adolescents with osteogenesis imperfecta: effect of intravenous pamidronate therapy.J Bone Miner Res. 2003; 18: 610-614
- Rapid increase in grip force after start of pamidronate therapy in children and adolescents with severe osteogenesis imperfecta.Pediatrics. 2003; 111: e601-e603
- Effect of intravenous pamidronate therapy on functional abilities and level of ambulation in children with osteogenesis imperfecta.J Pediatr. 2006; 148: 456-460
- Height and weight development during four years of therapy with cyclical intravenous pamidronate in children and adolescents with osteogenesis imperfecta types I, III, and IV.Pediatrics. 2003; 111: 1030-1036
- Treatment of symptomatic pediatric osteoporosis with cyclic single-day intravenous pamidronate infusions.J Pediatr. 2003; 142: 417-423
- Short-term safety assessment in the use of intravenous zoledronic acid in children.J Pediatr. 2004; 145: 701-704
- Bisphosphonate-induced radiographic changes in two pediatric patients with rheumatic diseases.Skeletal Radiol. 2004; 33: 732-736
- Two-year clinical trial of oral alendronate versus intravenous pamidronate in children with osteogenesis imperfecta.J Bone Miner Res. 2006; 21: 132-140
- Modern approach to children with osteogenesis imperfecta.J Pediatr Orthop B. 2003; 12: 77-87
- Osteogenesis imperfecta in childhood: treatment strategies.Arch Phys Med Rehabil. 1998; 79: 1590-1594
- Intravenous pamidronate treatment in children with moderate-to-severe osteogenesis imperfecta: assessment of indices of dual-energy X-ray absorptiometry and bone metabolic markers during the first year of therapy.Bone. 2004; 34: 539-546
- Effects of intravenous pamidronate treatment in infants with osteogenesis imperfecta: clinical and histomorphometric outcome.J Bone Miner Res. 2005; 20: 1235-1243
- Intravenous neridronate in children with osteogenesis imperfecta: a randomized controlled study.J Bone Miner Res. 2005; 20: 758-763
- The effects of intravenous pamidronate on the bone tissue of children and adolescents with osteogenesis imperfecta.J Clin Invest. 2002; 110: 1293-1299
- Zoledronic acid: a review of its use in the management of bone metastases and hypercalcaemia of malignancy.Drugs. 2003; 63: 417-437
- Use of bisphosphonate therapy for osteoporosis in childhood and adolescence.J Paediatr Child Health. 2003; 39: 88-92
- Pamidronate in children with osteogenesis imperfecta: histomorphometric effects of long-term therapy.J Clin Endocrinol Metab. 2006; 91: 511-516
- The pathogenesis, epidemiology, and management of glucocorticoid-induced osteoporosis.Calcif Tis Int. 2006; 75: 129-137
- Attempted randomized controlled trial of pamidronate versus calcium and calcitriol supplements for management of steroid-induced osteoporosis in children and adolescents.J Paediatr Child Health. 2005; 41: 580-582
- Low doses of pamidronate to treat osteopenia in children with severe cerebral palsy: a pilot study.Dev Med Child Neurol. 2006; 48: 709-712
- Oral bisphosphonates to treat disuse osteopenia in children with disabilities: a case series.J Pediatr Orthop. 2005; 25: 326-331
- Adverse effects of bisphosphonates. A comparative study.Drug Saf. 1996; 14: 158-170
- Effectiveness of pretreatment in decreasing adverse events associated with pamidronate in children and adolescents.Pharmacotherapy. 2004; 24: 195-197
- Delayed osteotomy but not fracture healing in pediatric osteogenesis imperfecta patients receiving pamidronate.J Bone Miner Res. 2004; 19: 1779-1786
- Bisphosphonate-associated osteonecrosis of the jaw: a literature review and clinical practice guidelines.J Dent Hyg. 2006; 80: 10
- Bisphosphonate-induced osteopetrosis.N Engl J Med. 2003; 349: 457-463
- Insulin-like growth factors and bone: the osteoporosis connection revisited.Proc Soc Exp Biol Med. 1998; 219: 1-7
- Effects of recombinant human growth hormone on metabolic indices, body composition, and bone turnover in healthy elderly women.J Clin Endocrinol Metab. 1994; 79: 470-479
- Effects of short-term recombinant human insulin-like growth factor I administration on bone turnover in osteopenic women with anorexia nervosa.J Clin Endocrinol Metab. 1996; 81: 3864-3870
- Growth hormone improves bone mineral content in children with cystic fibrosis.J Pediatr Endocrinol Metab. 2005; 18: 589-595
- A retrospective study of growth hormone use in adolescents with cystic fibrosis.Clin Endocrinol (Oxf). 2005; 62: 560-566
- New anabolic therapies in osteoporosis.Endocrinol Metab Clin North Am. 2003; 32: 285-307
- Effect of parathyroid hormone (1–34) on fractures and bone mineral density in postmenopausal women with osteoporosis.N Engl J Med. 2001; 344: 1434-1441
- Randomised controlled study of effect of parathyroid hormone on vertebral bone mass and fracture incidence among postmenopausal women on oestrogen with osteoporosis.Lancet. 1997; 350: 550-555
- The effect of teriparatide [human parathyroid hormone (1-34)] therapy on bone density in men with osteoporosis.J Bone Miner Res. 2003; 18: 9-17
- Parathyroid hormone treatment can reverse corticosteroid-induced osteoporosis. Results of a randomized controlled clinical trial.J Clin Invest. 1998; 102: 1627-1633
- The incorporation and removal of large amounts of strontium by physiologic mechanisms in mineralized tissues.Calcif Tissue Res. 1968; 2: 242-252
- Strontium induces murine keratinocyte differentiation in vitro in the presence of serum and calcium.J Cell Physiol. 1993; 154: 643-653
- The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis.N Engl J Med. 2004; 350: 459-468
- Oral statins and increased bone mineral density in postmenopausal women.Lancet. 2000; 355: 2218-2219
- HMG-CoA reductase inhibitors and the risk of hip fractures in elderly patients.JAMA. 2000; 283: 3211-3216
- Simvastatin increases serum osteocalcin concentration in patients treated for hypercholesterolaemia.J Clin Endocrinol Metab. 2001; 86: 4556-4559
- Regulation of osteoclast differentiation by statins.J Musculoskelet Neuronal Interact. 2003; 3: 53-62
- Slow-release sodium fluoride in osteoporosis.J Bone Miner Res. 1996; 11: 561-564
- Clinical trial of fluoride therapy in postmenopausal osteoporotic women: extended observations and additional analysis.J Bone Miner Res. 1994; 9: 265-275
- Monofluorophosphate combined with hormone replacement therapy induces a synergistic effect on bone mass by dissociating bone formation and resorption in postmenopausal women: a randomized study.J Clin Endocrinol Metab. 1999; 84: 3013-3020
- Treatment of osteoporosis in men with fluoride alone or in combination with bisphosphonates.Calcif Tissue Int. 2001; 69: 252-255
- Age-specific fluoride exposure in drinking water and osteosarcoma (United States).Cancer Causes Control. 2006; 17: 421-428
Article info
Identification
Copyright
© 2007 Elsevier Inc. Published by Elsevier Inc. All rights reserved.
